These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15967789)

  • 1. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: treatment of anaemia with iron.
    Vaage-Nilsen O
    Nephrol Dial Transplant; 2005 Jul; 20(7):1512-3; author reply 1513-4. PubMed ID: 15967789
    [No Abstract]   [Full Text] [Related]  

  • 2. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
    Locatelli F; Covic A; Macdougall IC; Wiecek A;
    J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A; Covic A; Locatelli F; Macdougall IC;
    Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure.
    Nephrol Dial Transplant; 1999; 14 Suppl 5():1-50. PubMed ID: 10513295
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron therapy in chronic kidney disease: current controversies.
    Kovesdy CP; Kalantar-Zadeh K
    J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia.
    Pedrazzoli P; Rosti G; Secondino S; Siena S
    Cancer; 2009 Mar; 115(6):1169-73. PubMed ID: 19152436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
    Repetto L; Moeremans K; Annemans L;
    Cancer Treat Rev; 2006; 32 Suppl 2():S5-9. PubMed ID: 16725267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron deficiency in renal anemia is difficult to diagnose. Evidence-based guidelines improve diagnosis and treatment].
    Bárány P
    Lakartidningen; 2005 Sep 12-18; 102(37):2536-7. PubMed ID: 16200898
    [No Abstract]   [Full Text] [Related]  

  • 9. Creating a better environment to treat anemia in patients with CKD.
    Sinnen MT
    Nephrol Nurs J; 2007; 34(6):645-9. PubMed ID: 18203573
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
    Vaziri ND
    Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
    Swinkels DW; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2450-3. PubMed ID: 18495744
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
    Rostoker G; Griuncelli M; Loridon C; Couprie R; Benmaadi A; Bounhiol C; Roy M; Machado G; Janklewicz P; Drahi G; Dahan H; Cohen Y
    Am J Med; 2012 Oct; 125(10):991-999.e1. PubMed ID: 22998881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finding the magic formula for ESA use.
    Neumann ME
    Nephrol News Issues; 2010 May; 24(6):8. PubMed ID: 20509399
    [No Abstract]   [Full Text] [Related]  

  • 15. Current and future challenges in anaemia management.
    Levin A; Locatelli F; Muirhead N; Ritz E
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi1-2. PubMed ID: 15958819
    [No Abstract]   [Full Text] [Related]  

  • 16. European best practice guidelines 9-13: anaemia management.
    Jacobs C; Hörl WH; Macdougall IC; Valderrábano F; Parrondo I; Abraham IL; Segner A
    Nephrol Dial Transplant; 2000; 15 Suppl 4():33-42. PubMed ID: 11052147
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
    Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
    An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice.
    Limrick C; McNichols-Thomas C
    J Ren Care; 2009 Mar; 35 Suppl 1():94-100. PubMed ID: 19222739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European best practice guidelines 1-4: evaluating anaemia and initiating treatment.
    Valderrábano F; Hörl WH; Jacobs C; Macdougall IC; Parrondo I; Cremers S; Abraham IL
    Nephrol Dial Transplant; 2000; 15 Suppl 4():8-14. PubMed ID: 11052144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.